{"id":38378,"date":"2026-03-25T01:31:25","date_gmt":"2026-03-25T08:31:25","guid":{"rendered":"https:\/\/www.novogene.com\/us-en\/?post_type=resources&p=38378"},"modified":"2026-03-25T20:18:01","modified_gmt":"2026-03-26T03:18:01","slug":"single-cell-immune-repertoire-sequencing-applications-technical-challenges-and-future-perspectives","status":"publish","type":"resources","link":"https:\/\/www.novogene.com\/us-en\/resources\/blog\/single-cell-immune-repertoire-sequencing-applications-technical-challenges-and-future-perspectives\/","title":{"rendered":"Single-Cell Immune Repertoire Sequencing: Applications, Technical Challenges, and Future Perspectives"},"content":{"rendered":"
\n<\/p>\n

I. Applications of Single-Cell Immune Repertoire Technologies and Highlighted Case Studies <\/strong><\/p>\n

Single-cell immune repertoire technologies have been widely adopted across diverse areas of immunological research:<\/p>\n

Tumor Immunology<\/strong><\/p>\n

Characterizing clonal expansion, exhaustion signatures, and functional reprogramming of tumor-infiltrating T cells during cancer immunotherapy, including checkpoint blockade and adoptive cell transfer.<\/p>\n

Case Study 1: Clonal Dynamics in Cancer Immunotherapy<\/strong><\/a><\/p>\n\n\n\n\n
Journal<\/strong>\n<\/td>\nNature Cancer\n<\/td>\nImpact Factor<\/strong>\n<\/td>\n28.5\n<\/td>\n<\/tr>\n
Time<\/strong>\n<\/td>\n2022.01\n<\/td>\nResearch Subject<\/strong>\n<\/td>\nHuman tumor biopsies\n<\/td>\n<\/tr>\n
Research Institution<\/strong>\n<\/td>\nPeking University\n<\/td>\nLibrary type<\/strong>\n<\/td>\n10x Genomics 5\u2019 scRNA-seq + Immune Profiling\n<\/td>\n<\/tr>\n<\/table>\n

Clonal analysis of tumor-infiltrating T cells in lung cancer patients undergoing immunotherapy revealed that expanded Th1 clones were significantly enriched in treatment responders compared to non-responders. Integration with published basal cell carcinoma datasets further validated the critical role of clonally expanded Th1 cells in mediating responses to immune checkpoint blockade across cancer types1<\/sup>.<\/p>\n

Infection and Vaccine Studies<\/strong><\/p>\n

Investigating the formation, clonal selection, and long-term maintenance of antigen-specific T and B cell responses following infection or vaccination.<\/p>\n

Case Study 2: Multi-omics Immune Profiling in Omicron Breakthrough Infection<\/strong><\/a><\/p>\n<\/p>\n\n\n\n\n
Journal<\/strong>\n<\/td>\nImmunity\n<\/td>\nImpact Factor<\/strong>\n<\/td>\n26.3\n<\/td>\n<\/tr>\n
Time<\/strong>\n<\/td>\n2023.06\n<\/td>\nResearch Subject<\/strong>\n<\/td>\nHuman PBMC\n<\/td>\n<\/tr>\n
Research Institution<\/strong>\n<\/td>\nChinese Academy of Medical Sciences & Peking Union Medical
\n College\n<\/td>\n		Service Provided<\/strong>\n<\/td>\n10x Genomics 5\u2019 scRNA-seq + Immune Profiling\n<\/td>\n<\/tr>\n<\/table>\n

Integrated multi-omics profiling of blood samples from SARS-CoV-2 Omicron patients revealed dynamic immune and platelet responses across disease stages. Single-cell and immune repertoire analyses identified enhanced interferon-driven platelet activity and extensive platelet\u2013leukocyte interactions that modulate immune function. Notably, re-positive patients exhibited reduced B cell receptor clonality, impaired antibody production, and decreased neutralizing capacity. These findings highlight the power of multi-omics and single-cell TCR\/BCR sequencing to characterize immune dysregulation and predict disease outcomes in viral infections2<\/sup>.<\/p>\n

<\/p>\n

Autoimmune Diseases<\/strong><\/p>\n

Identifying pathogenic clonally expanded populations and dissecting their functional states to elucidate disease mechanisms and potential therapeutic targets.<\/p>\n

Case Study 3: B Cell\u2013Mediated Tolerance in Neuromyelitis Optica<\/strong><\/a><\/p>\n\n\n\n\n
Journal<\/strong>\n<\/td>\nNature\n<\/td>\nImpact Factor<\/strong>\n<\/td>\n48.5\n<\/td>\n<\/tr>\n
Time<\/strong>\n<\/td>\n2024.02\n<\/td>\nResearch Subject<\/strong>\n<\/td>\nmouse lymph nodes, spleen and thymus, etc\n<\/td>\n<\/tr>\n
Research Institution<\/strong>\n<\/td>\nTechnical University of Munich School of Medicine and Health\n<\/td>\nService Provided<\/strong>\n<\/td>\n10x Genomics 5\u2019 scRNA-seq + Immune Profiling\n<\/td>\n<\/tr>\n<\/table>\n

Analysis of immune tolerance mechanisms revealed that B cells can intrinsically express and present the autoantigen AQP4 upon CD40 activation, enabling the deletion of AQP4-specific T cell clones in the thymus. Thymic B cells were shown to play a critical role in shaping the TCR repertoire by mediating central tolerance, and loss of AQP4 expression in B cells led to the escape of autoreactive T cells and enhanced autoantibody production. These findings highlight a noncanonical role of B cells in immune tolerance and provide a framework for studying autoreactive clonal selection using single-cell TCR\/BCR sequencing3<\/sup>.<\/p>\n

Immune Cell Therapy Research<\/strong><\/p>\n

Enabling high-resolution clonal tracking and functional profiling in TCR-engineered T cell (TCR-T) and chimeric antigen receptor T cell (CAR-T) therapies to assess clonal dominance, persistence, and therapeutic efficacy.<\/p>\n

Case Study 4: Targeting Pro-inflammatory T Cells in Atherosclerosis<\/strong><\/a><\/p>\n<\/p>\n\n\n\n\n
Journal<\/strong>\n<\/td>\nCell Research\n<\/td>\nImpact Factor<\/strong>\n<\/td>\n25.9\n<\/td>\n<\/tr>\n
Time<\/strong>\n<\/td>\n2024. 03\n<\/td>\nResearch Subject<\/strong>\n<\/td>\nAtherosclerosis\n<\/td>\n<\/tr>\n
Research Institution<\/strong>\n<\/td>\nThe Second Affiliated Hospital, Zhejiang University School of Medicine\n<\/td>\nService Provided<\/strong>\n<\/td>\n10x Genomics 5\u2019 scRNA-seq + Immune Profiling\n<\/td>\n<\/tr>\n<\/table>\n

Single-cell multi-omics analysis of atherosclerotic plaques identified a population of activated, pro-inflammatory PD-1\u207a T cells contributing to disease progression. Clinical cohort studies revealed that anti\u2013PD-1 monoclonal antibodies with Fc\u03b3R-binding capability significantly reduced plaque size by interacting with myeloid Fc\u03b3 receptors and functionally suppressing PD-1\u207a T cells in ligand-deficient environments. These findings highlight a novel immunomodulatory mechanism and support T cell\u2013targeted therapies as a potential strategy for resolving atherosclerosis, which can be further dissected using single-cell TCR profiling to track pathogenic clonal populations4<\/sup>.<\/p>\n

II. Technical Challenges and Limitations<\/strong><\/p>\n

Despite its transformative capabilities, single-cell TCR sequencing faces several technical and analytical challenges:<\/p>\n

\n
\n

1. Incomplete Chain Recovery<\/strong><\/p>\n

Not all cells yield complete paired TCR chains due to capture efficiency limitations and stochastic chain dropout, which can complicate clonotype assignment and frequency estimation.<\/p>\n

2. Sampling Bias for Rare Clones<\/strong><\/p>\n

Low-frequency clonotypes may be underrepresented or missed entirely due to limited cell sampling depth, potentially obscuring biologically relevant rare clones.<\/p>\n<\/div>\n

\n
<\/div>\n

\n<\/div>\n<\/div>\n

3. Lack of Standardized Clonotype Definitions<\/strong><\/p>\n

Variability in clonotype calling criteria (e.g., CDR3 sequence identity thresholds, gene usage requirements) across studies hinders cross-study comparisons and meta-analyses.<\/p>\n

4. Unknown Antigen Specificity<\/strong><\/p>\n

TCR sequences alone do not reveal antigen specificity, requiring orthogonal functional validation approaches such as peptide-MHC multimer staining or high-throughput screening.<\/p>\n

5. Cost and Scalability Constraints<\/strong><\/p>\n

Single-cell methods remain significantly more expensive and lower throughput compared to bulk repertoire sequencing, limiting their application in large-scale population studies.<\/p>\n

<\/p>\n

III. Future Directions and Emerging Technologies<\/strong><\/p>\n

Ongoing developments are expanding the scope and impact of single-cell immune repertoire profiling:<\/p>\n

1. Multi-Omics Integration<\/strong><\/p>\n

Coupling immune repertoire data with epigenomic profiling (e.g., ATAC-seq, DNA methylation), surface proteomics (e.g., CITE-seq), and spatial transcriptomics to achieve comprehensive, spatially resolved characterization of clonal states.<\/p>\n

2. Machine Learning\u2013Based Antigen Specificity Prediction<\/strong><\/p>\n

Developing computational models that leverage TCR\/BCR sequence features and structural information to predict antigen specificity, reducing reliance on experimental validation and enabling large-scale epitope mapping.<\/p>\n

\n
\n

3. Spatiotemporal Clonal Tracking<\/strong><\/p>\n

Integrating spatial technologies with longitudinal sampling strategies to trace clonal migration, tissue residence, and dynamic functional transitions across anatomical compartments and time points.<\/p>\n

4. Clinical Translation and Precision Medicine<\/strong><\/p>\n

Advancing translational applications in immunotherapy response prediction, patient stratification in autoimmune diseases, vaccine immunogenicity assessment, and minimal residual disease monitoring in lymphoid malignancies.<\/p>\n<\/div>\n

\n
<\/div>\n

\n<\/div>\n<\/div>\n

Reference<\/strong><\/p>\n

    \n
  1. Liu, B., Hu, X., Feng, K. et al. Temporal single-cell tracing reveals clonal revival and expansion of precursor exhausted T cells during anti-PD-1 therapy in lung cancer. Nat Cancer 3, 108\u2013121 (2022).<\/li>\n
  2. Wang H, Liu C, Xie X., et al. Multi-omics blood atlas reveals unique features of immune and platelet responses to SARS-CoV-2 Omicron breakthrough infection. Immunity, 2023; 56, 1410-1428.e8<\/li>\n
  3. Afzali, A.M., Nirschl, L., Sie, C. et al. B cells orchestrate tolerance to the neuromyelitis optica autoantigen AQP4. Nature 627, 407\u2013415 (2024). <\/li>\n
  4. Fan, L., Liu, J., Hu, W. et al. Targeting pro-inflammatory T cells as a novel therapeutic approach to potentially resolve atherosclerosis in humans. Cell Res 34, 407\u2013427 (2024).<\/li>\n<\/ol>\n

    <\/a>\u00a0<\/p>\n<\/div>\n

    \n
    <\/div>\n
    CLAIM PROMO<\/a><\/div>\n<\/div>\n